Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Canakinumab (Pf) 150 Mg/ml Subcutaneous Solution (CPT 78073) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 18, 2026 , from http://ppman.hank.ai/transparency/procedure/78073/by-state?code_type=CPT
“Canakinumab (Pf) 150 Mg/ml Subcutaneous Solution (CPT 78073) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/78073/by-state?code_type=CPT. Accessed
October 18, 2026 .
“Canakinumab (Pf) 150 Mg/ml Subcutaneous Solution (CPT 78073) by State,” HANK Price Transparency ,
accessed October 18, 2026 ,
http://ppman.hank.ai/transparency/procedure/78073/by-state?code_type=CPT.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CPT · across United States
78073 — Canakinumab (Pf) 150 Mg/ml Subcutaneous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$38,651
National median
$4,939 – $39,165
IQR (p25 – p75)
2
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 78073 (CPT), with interquartile range
State Median p25 p75
NE $39,062 $38,651 $39,473
NJ $17 $17 $19